has served as the definitive reference for the global GI community . The newly released 12th edition
remains the "gold standard" reference for gastroenterologists, hepatologists, and trainees, offering a comprehensive blend of basic science, clinical diagnosis, and the latest management strategies. s gastrointestinal and liver disease 12th edition
: Addresses contemporary challenges with new chapters on the GI and hepatic manifestations of Coronavirus and enterocolitis induced by cancer immunotherapy . has served as the definitive reference for the
C (Resmetirom – first FDA-approved agent specifically for MASLD with fibrosis; vitamin E and pioglitazone are alternatives but not first-line per 2025–2026 guidelines) s gastrointestinal and liver disease 12th edition